Decoded
Decoded
Podcast Description
Decoded is the podcast hosted by Dr. Jurgi Camblong - Founder and CEO of SOPHiA GENETICS, molecular biologist, and global leader and pioneer of data-driven medicine.In each episode, he connects with world-class scientists, clinicians, innovators, and policymakers to uncover how data, technology, and clinical expertise converge to transform care.From accelerating cancer diagnostics to transforming the understanding of rare and inherited disorders, Decoded goes beyond the buzz to reveal how innovation translates into real outcomes for patients worldwide.With a sharp focus on multimodal data, AI in healthcare, and global equal access to patient care, Decoded goes beyond theory to decode what’s working - and what it takes to scale innovation that truly improves lives.
Podcast Insights
Content Themes
The podcast centers on topics such as multimodal data utilization, AI in healthcare, and equitable access to medical care, with specific episodes like 'Liquid Biopsy Decoded' exploring advancements in cancer diagnostics and discussions on the integration of molecular insights to personalize treatments and improve clinical outcomes.
Decoded is the podcast hosted by Dr. Jurgi Camblong – Founder and CEO of SOPHiA GENETICS, molecular biologist, and global leader and pioneer of data-driven medicine.
In each episode, he connects with world-class scientists, clinicians, innovators, and policymakers to uncover how data, technology, and clinical expertise converge to transform care.
From accelerating cancer diagnostics to transforming the understanding of rare and inherited disorders, Decoded goes beyond the buzz to reveal how innovation translates into real outcomes for patients worldwide.
With a sharp focus on multimodal data, AI in healthcare, and global equal access to patient care, Decoded goes beyond theory to decode what’s working – and what it takes to scale innovation that truly improves lives.
What happens when the mind behind the Mars Rovers turns its attention to fighting cancer and developing next-generation medicines?
Today, Thomas Fuchs is the Chief AI Officer at Eli Lilly & Company, but he started his career at NASA, building the AI that helped rovers navigate the surface of Mars. He soon realized that the same math used to distinguish sand from rocks could be used to identify cancer cells on a pathology slide. He transitioned to healthcare, coined the term ”computational pathology”, and secured the first-ever FDA approval for an AI solution in cancer pathology after founding Paige.ai.
In this episode, Thomas joins Dr. Jurgi Camblong to discuss his journey, including how to build trust around AI, the massive potential of the technology for medicine discovery, and what the future holds for medicine.
Because better outcomes don’t come from better algorithms alone—they come from pioneers brave enough to trust them.
For more information on this episode follow the link below:
https://www.linkedin.com/in/jurgicamblong/
https://www.sophiagenetics.com/podcasts/
#AIinHealthcare #DrugDiscovery #GenerativeAI #EliLilly #DecodedPodcast
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.